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The 3D structure of the influenza virus polymerase complex was
determined by electron microscopy and image processing of re-
combinant ribonucleoproteins (RNPs). The RNPs were generated by
in vivo amplification using cDNAs of the three polymerase sub-
units, the nucleoprotein, and a model virus-associated RNA con-
taining 248 nt. The polymerase structure obtained is very compact,
with no apparent boundaries among subunits. The position of
specific regions of the PB1, PB2, and PA subunits was determined
by 3D reconstruction of either RNP–mAb complexes or tagged
RNPs. This structural model is available for the polymerase of a
negative-stranded RNA virus and provides a general delineation of
the complex and its interaction with the template-associated
nucleoprotein monomers in the RNP.
Many viruses contain RNA as genetic material and useRNA-dependent RNA polymerases as enzymes for rep-
lication and transcription. The atomic structures of several viral
RNA (vRNA)-dependent RNA polymerases from positive- and
double-stranded RNA viruses are available (1–6). These pro-
teins show little sequence homology with other DNA-dependent
polymerases but contain specific sequence motifs shared with
other polymerases (7). They show a typical right-hand fold that
includes the thumb, finger, and palm domains, the last of which
contains the conserved sequence motifs involved in polymerase
catalysis. These polymerases are medium-size proteins that show
activity in vitro, although viral replication and transcription in
vivo are carried out by polymerase-containing macrocomplexes.
In these, other viral and cellular factors contribute to the
efficiency and regulation of the polymerase or to the localization
of the RNA synthetic machinery in the infected cell (reviewed in
ref. 8).
The situation in negative-strand viruses (NSVs) is different.
The templates for transcription and replication are ribonucleo-
proteins (RNPs) in which the negative-stranded RNA is com-
plexed with the nucleoprotein (NP) and associated to the
polymerase. In the NSVs, the polymerase is a very large protein,
the L protein ( 250 kDa, except in the Orthomyxoviridae), which
consists of a heterotrimer of similar aggregate size. The repli-
cation intermediates are RNPs similar to virion RNPs but
containing positive-stranded RNA. Other viral proteins, such as
the P protein for nonsegmented NSVs, and cellular factors are
essential for transcription or replication of NSV RNPs. As a
consequence of this complexity, very little structural information
is available on NSV polymerases.
Within the NSVs, influenza A viruses are distinct in having a
segmented genome and replicating in the cell nucleus (9). Their
genome consists of eight RNPs that are transcribed and repli-
cated by the viral polymerase, a heterotrimer composed by the
PB1, PB2, and PA subunits (10, 11). Replication of vRNA
involves de novo initiation of nascent RNA chains, whereas
initiation of mRNA synthesis requires the generation of capped
primers from cellular heterogeneous nuclear RNAs by a cap-
stealing mechanism (12). Transcription termination needs the
interaction of the polymerase with 5 terminal sequences of the
template (13) and occurs at the polyadenylation signal, which
consists of an oligo-U sequence (14, 15).
Our knowledge about influenza polymerase has increased
over the years. Regions of each subunit involved in complex
formation have been defined (16–19), and the domains in the
PB1 subunit that bind vRNA and cRNA have been determined
(20–22). The PB1 subunit harbors the polymerase activity (7,
23), but the function of other subunits is becoming more diffuse.
The PB2 subunit is a cap-binding protein (24), but the endonu-
clease activity has been located in the PB1 subunit (25). In
addition, mutations in the N-terminal region of the PB2 subunit
alter the viral replication capacity but not the transcription
activity of RNPs (26). The PA subunit has been associated with
the replication activity of the polymerase (27, 28). However, a
PA mutation has been reported that abolishes cap-snatching but
not RNA replication (29). On the other hand, our knowledge
about the structure of the influenza virus RNP and its polymer-
ase is very limited. Virion RNPs are supercoiled ribbon struc-
tures (30, 31) with the polymerase at one end of the supercoil
(32), in association with both vRNA ends (33). vRNA–NP
complexes or RNA-free NPs form structures similar to natural
RNPs (34). More recently, we have reported the 3D reconstruc-
tion of recombinant RNPs containing short model vRNAs (35,
36). Here, we report the structure at a 23-Å resolution of the
polymerase complex present in these RNPs, as determined by
electron microscopy and image processing, and the localization
of specific subunit domains by 3D reconstruction of tagged
RNPs and RNP–mAb complexes.
Materials and Methods
Biological Materials. Plasmids pGPB1, pGPB2, pGPA, and pGN-
P(poly)A have been described (37). Plasmid pT7NSRT clone
23, encoding a 248-nt model vRNA under a T7 promoter and the
hepatitis  ribozyme, has been described (35). Plasmid pBS1479
(38), containing the tandem affinity purification (TAP) tag, was
provided by B. Se´raphin (Centre National de la Recherche
Scientifique, Gif-sur-Yvette, France). mAbs specific for PA and
PB2 have been described (39).
Mutant Construction. For construction of the pGEMPB2-His
plasmid, a PB2 ORF was amplified with a forward primer
containing a NcoI site at the initiation codon. The PCR product
was digested with NcoI and EcoRI and cloned into pTRC2B
plasmid in-frame with the vector C-terminal His tag. The
His-tagged PB2 gene was subcloned into pGPB2 by exchanging
the PflmI–ScaI restriction fragment. The pGPB2-TAP plasmid
was constructed by replacement of the BsaBI–XbaI fragment of
pGPB2 (40 bp, containing the C terminus of the PB2 ORF) by
a PCR product of the TAP tag. The forward primer contained
the codons of PB2 that were eliminated by excision of the
BsaBI–XbaI fragment, thereby restoring a complete TAP-tagged
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PB2 gene. To generate the pGPB1-TAP plasmid, the PB2 ORF
present in pGPB2-TAP was eliminated by restriction with KpnI
and BamHI and replaced by a PCR product of the PB1 ORF.
The structure of the plasmids was tested by restriction analysis
and sequencing. The expression of the encoded tagged protein
was ascertained by infectiontransfection (35) and Western
blotting with anti-polymerase and anti-tag Abs. The functional-
ity of the recombinant proteins was tested by reconstitution of
RNPs as indicated below.
Reconstitution and Purification of Recombinant RNPs. Reconstitu-
tion and in vivo amplification of recombinant RNPs was carried
out essentially as described (35, 36) by transfection of vaccinia
vTF7-3-infected cells with plasmids pGPB1, pGPB2, pGPA,
pGNP(poly)A, and pT7NSRT clone 23. In the appropriate
experiments, plasmids pGPB2-His or pGPB1-TAP were substi-
tuted for the corresponding WT plasmids. For purification of
His-tagged RNPs, the clarified extract was centrifuged in a
glycerol step gradient in TN buffer (150 mM NaCl50 mM
TrisHCl, pH 7.8) for 17 h at 35,000 rpm and 4°C in a SW41 rotor.
Occasionally, the centrifugation step was repeated under the
same conditions. The transcriptionally active fractions were
diluted to 5 ml in 50 mM TrisHCl100 mM NaCl5 mM
MgCl20.1% Nonidet P-4020 mM imidazol (pH 8.0) and incu-
bated with an Ni2-NTA agarose resin for 12–14 h at 4°C, and
the resin was washed 10 times with 10 column volumes of the
same buffer. The bound His-tagged RNPs were eluted with 50
mM TrisHCl100 mM KCl100 mM EDTA (pH 8.0). For
purification of RNP–Ab complexes, the active fractions after the
first glycerol step gradient were incubated with excess purified
mAb, and the mixture was centrifuged again in a similar glycerol
gradient. Finally, the RNP–Ab complexes were purified on an
Ni2-NTA agarose column as described above.
Protein Analyses. mAbs were purified from culture supernatants
by chromatography on IgG purification resin (Stratagene). West-
ern blotting was carried out as described (35), by using a mixture
of anti-PA or anti-PB2 mAbs, anti-PB1, or anti-NP serum. The
His tag was revealed with anti-His IgG coupled to peroxidase.
The TAP tag was revealed with unrelated rabbit Ab. Rabbit IgGs
were revealed with biotin-labeled goat anti-rabbit Ab. For silver
staining, the gels were fixed for 30 min each in 25% ethanol
10% acetic acid and 25% ethanol0.5% acetic acid, soaked twice
for 20 min in silver nitrate (1.8 gliter), and washed three times
with H2O. Reduction was made in 10 mM NaBH40.75 M
NaOH0.75% formaldehyde, and the reaction was stopped in
10% acetic acid.
Electron Microscopy and Image Processing. Samples were applied to
carbon-coated copper grids previously glow-discharged at low
air pressure, stained with 2% uranyl acetate, and visualized in a
JEOL 1200 EXII microscope at a nominal magnification of
40,000 and a defocus range of 3,000–5,000 Å. Photographic
plates exposed under a low-dose protocol were digitized at 3.5 Å
per pixel. Individual images were processed in 2D and aligned by
cross-correlation free-pattern methods (40) by using the XMIPP
package (41). When appropriate, the images were subjected to
Kohonen’s self-organizing feature maps (42). Homogeneous
populations were obtained and averaged. For 3D reconstruction,
the sample stage was tilted 30°. The model was refined by using
the angular refinement algorithms provided by SPIDER (43),
and the reconstruction was performed by using ART (44). The
handedness of the reconstructed volumes was chosen arbitrarily
because of the intrinsic ambiguity generated by the electron
microscopy reconstruction procedure. The resolution of the
model was estimated by Fourier ring correlation of two inde-
pendent reconstructions, and these values were used to low-pass
filter the volume in the final model.
Results and Discussion
Purification of His-Tagged, Recombinant RNPs Generated by in Vivo
Amplification. We have reported the structural characterization
of influenza virus recombinant RNPs containing a 248-nt model
vRNA (35, 36) that were generated by in vivo amplification and
purified by successive glycerol gradient centrifugations. To in-
crease the purity and yield of recombinant RNPs and to allow the
structural analysis of the polymerase complex, we incorporated
in the RNP tags for affinity purification. Because the RNPs were
amplified by replication in transfected cells, the presence of the
tag should not have impaired the ability of the polymerase to
replicate. Addition of a C-terminal His tag at the PB2 subunit did
not affect replication or transcription of His-tagged RNPs (data
not shown). They were purified by gradient centrifugation to
separate them from soluble proteins and by affinity chromatog-
raphy on an Ni2-NTA agarose resin. In the purified RNP
preparations, the polymerase proteins, the NP, and the vRNA
model were prominent after silver staining (Fig. 1, star; compare
the samples with and without RNase treatment), as compared
with control preparations in which the template RNA was
omitted.
3D Reconstruction of the Viral Polymerase Complex. His-tagged
RNPs were analyzed by electron microscopy of stained samples,
and images from individual RNPs were collected from tilted
samples. The polymerase and the adjacent NP monomers from
each RNP image were extracted, and the images obtained were
centered on the polymerase, aligned, and averaged. These
images were used for 3D reconstruction, using as initial model
the volume of the polymerase present in the 3D reconstruction
of the RNP (36) and using a radius that would exclude the
information derived from the NP monomers. The final model
obtained (Fig. 2 A–D) was derived from 11,194 images and
acquired from some 500 photographic plates, and the resolution
obtained was 23 Å. The isosurface presented (Fig. 2 A–D Upper)
corresponds to a volume of approximately the molar mass of the
polymerase complex. The structure is very compact and does not
reflect the N- to C-terminal arrangement of the subunits de-
duced from in vitro interaction studies (16–19). This observation
Fig. 1. Purification of recombinant mini-RNPs. RNPs were reconstituted and
amplified in vivo by using His-tagged PB2 (His). As a control, a reconstitution
was performed in the absence of RNA (CTRL). RNP preparations after glycerol
gradient centrifugation (Input) and after elution from Ni2-NTA agarose
(RNPs) were analyzed by silver staining. The positions of the RNP components
are indicated to the right and that of vRNA is indicated by a star. The molecular
mass markers (in kDa) are indicated to the left. MW, molecular weight.
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is strengthened by the fact that a low-threshold illustration of the
volume (Fig. 2 A–D Lower), which indicates areas of the highest
density, does not reveal the boundaries among subunits. The
polymerase complex shows an area of lower density (Fig. 2 C and
D, arrows) in which a groove could be present, although at the
resolution reached it is not possible to establish it unambigu-
ously. The topology of the polymerase structure in the context
of the complete RNP model is presented in Fig. 2 E and F. Two
specific mass accumulations are in close contact with the adja-
cent NP monomers in the RNP. These regions of the complex
may represent the polymerase–template NP interaction domains
and show different contact sizes. At present, it is not possible to
ascertain which polymerase subunits belong to these domains,
although biochemical data indicate that PB1 and PB2, but not
PA, proteins interact with soluble NP (45).
Localization of Specific Polymerase Domains by 3D Reconstruction of
Polymerase–Ab Complexes. To delineate the polymerase subunits
within the complex, we attempted the structural characterization
of RNP–mAb complexes. The Abs chosen (PB2–25 and PA-2)
recognize epitopes located within the N-terminal 113 aa in PB2
and the C-terminal region of PA (residues 400–716), respec-
tively. Complexes of RNPs and mAb IgGs of either specificity
contained polymerase, NP, and PB2- or PA-specific IgG,
whereas parallel preparations in which unrelated mAbs were
used did not show the presence of IgG (data not shown).
Each preparation of RNP–mAb complexes was processed
independently, and the images were classified by using a self-
organizing feature map (42). Fifteen, or 24%, of the images
corresponded to RNP–mAb complexes in the different data sets.
The average images from the complexes containing subunit-
specific mAbs showed additional densities at sites specific for
either PB2–25 IgG (Fig. 3B, arrow) or PA-2 IgG (Fig. 3C, arrow),
as compared with the full set of images (Fig. 3A). In view of these
results, we carried out 3D reconstructions of the polymerase–
mAb complexes, using the sets of images whose 2D averages are
shown in Fig. 3 B and C. As starting model in the refinement, we
used the 3D volume of the polymerase obtained from a similar
number of images of Ab-free RNPs; the results are presented in
Fig. 4. Additional masses showing the contact sites of the
monoclonal Fab fragments were detected in the 3D volumes of
RNP–PB2–25 and RNP–PA-2 complexes (Fig. 4 B and C) as
compared with the Ab-free polymerase (Fig. 4A). The 3D
models presented indicate that the N-terminal region of PB2
is located in the bulge of the polymerase, on the right side of
the front view (Fig. 4B Upper), whereas the C-terminal region
of PA is situated at the center of the complex, as seen in its
front view (Fig. 4C Upper); i.e., they are located opposite the
polymerase–NP interaction side.
Mapping PB1 Subunit Domains by 3D Reconstruction of Tagged
Polymerase Complexes. To localize the PB1 subunit in the poly-
merase, we prepared recombinant RNPs that contained a TAP
tag (38) of 170 aa at the C terminus of PB1. Recombinant
RNPs containing TAP-tagged PB1 and His-tagged PB2 were
purified as indicated above. The TAP tag was exposed at the
surface of the polymerase, because these double-tagged RNPs
could be efficiently retained on an IgG Sepharose column (data
not shown). Therefore, we prepared complexes of double-tagged
recombinant RNPs and purified unrelated rabbit IgG. These IgG
molecules recognize the protein A domain in the TAP tag by
their Fc regions and should provide a mass recognizable by
electron microscopy.
The purification of these RNP–TAP–IgG complexes is pre-
sented in Fig. 5A. The presence of PB1-TAP is apparent by the
increase in size of this subunit (from 757 to 927 aa) and its
reactivity in a Western blot with unrelated rabbit serum. In
addition, the presence of IgG molecules bound to the TAP-
tagged RNPs is apparent (Fig. 5A). Such IgG molecules were not
present in control untagged RNPs (data not shown). Images
from these complexes were obtained and processed for 3D
reconstruction as indicated above for RNP–mAb complexes, and
the results are shown in Fig. 5 B and C. An additional mass
Fig. 2. 3D reconstruction of the influenza virus polymerase complex. The
images of the polymerase complex from isolated RNPs were used for 3D
reconstruction. (A–D) The isosurface representations at a threshold that cor-
responds to the mass of the polymerase (Upper) and a lower threshold
representation (pink) under a transparent isosurface (Lower). They represent
the side views (A and C), front view (B), and rear view (D) of the model. The
arrows point to a possible groove in the complex. (E and F) Side views of the
3D model of a recombinant RNP (36) showing the relative topology of the new
model of the polymerase with regard to the NP ring. (Scale bars, 50 Å.)
Fig. 3. 2D average images of recombinant polymerase–mAb complexes. Images obtained from negative-stained preparations of RNP–PB2–25 and RNP–PA-2
complexes were centered and aligned. The average image obtained is presented in A. Sorting by a self-organizing feature map led to data collections lacking
or containing bound IgG. The average images obtained for the PB2–25- and PA-2-containing collections are presented in B and C, respectively. The arrows indicate
the additional masses observed. (Scale bar, 50 Å.)
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became apparent in the 3D model (Fig. 5C, arrows) as compared
with the WT polymerase (Fig. 5B), which is located opposite the
site where the N-terminal region of PB2 was mapped (Fig. 4B).
These results indicate that the C-terminal region of PB1 is
situated on the left of the polymerase complex as seen in its front
view.
Biological Implications of the Polymerase Structure. The influenza
virus polymerase is a heterotrimer with an aggregate molecular
mass of 250 kDa. The complex is quite stable and can be
purified by affinity chromatography on coexpression from
cDNAs with a variety of tags at different locations (E.T. and
E.A., unpublished results). These biochemical properties corre-
late with a very compact 3D structure, as described here (Figs.
2 and 6). The N-terminal region of PB2 and the C-terminal
region of PA are exposed at the surface of the polymerase
present in the RNP, as indicated by the possibility of forming
complexes with purified specific mAbs. The structural informa-
tion obtained from these complexes (Fig. 4) allowed the local-
ization of these regions of PB2 and PA subunits at specific sites
of the complex (Fig. 6A), opposite the domains of the polymer-
ase that interact with the adjacent NP monomers in the RNP
(Fig. 2 E and F). The localization of the C terminus of PB1 has
been accomplished by inserting a TAP tag downstream of the
gene. Because this sequence contributes some additional 170 aa
and can be labeled specifically with IgG, its position in the
Fig. 4. 3D reconstruction of polymerase–anti-PB2 and polymerase–anti-PA monoclonal complexes. The images at the bottom are the result of a 90° rotation
of those at the top. The images whose 2D averages are presented in B and C were used for 3D reconstruction. (A) The isosurface representation of the WT
polymerase is shown. (B and C) The corresponding models for polymerase–anti-PB2 and polymerase–anti-PA complexes, respectively, are shown. The arrows point
to the additional masses representing the domains of interaction of the mAb IgGs.
Fig. 5. 3D reconstruction of PB1-tagged influenza virus polymerase. (A) Purification of RNP–TAP–IgG complexes. RNPs were amplified by using TAP-tagged PB1
and His-tagged PB2, purified, and incubated with an excess of purified, unrelated rabbit IgGs. The RNP–TAP and RNP–TAP–IgG complexes were purified by affinity
chromatography on Ni2-NTA agarose. The successive Western blotting of the affinity-purified material is shown; unrelated rabbit serum was used to reveal the
TAP tag (anti-TAP), anti-PB2 rabbit serum (anti-PB2), and anti-rabbit IgG biotin (anti-IgG). Molecular mass markers (in kDa) are indicated to the left. (B and C)
The images obtained for RNP–TAP–IgG complexes were used for 3D reconstruction. Relevant views of the tagged polymerase (C) are presented in comparison
with WT polymerase (B). The arrows point to additional masses contributed by the TAP tag and the bound IgG. The lower images are the result of a 90° rotation
of the upper images.
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complex could be determined (Fig. 5 B and C). A similar strategy
was attempted to localize the C terminus of PA. However, the
low capacity of PA-TAP and PB2-His double-tagged RNPs to
replicate in vivo precluded their 3D study.
The 3D structure determined suggests the existence of a
low-density area in the center of the polymerase complex (see
Fig. 2 C and D, arrows) that may represent a groove for
interaction with the template or for the exit of the newly
synthesized RNA. The available evidence indicates that the NP
monomers recognize the template RNA by contacting the
sugar–phosphate backbone, leaving the bases accessible to
chemical modification (46). This accessibility would allow the
polymerase to use the NP–RNA complex as template without
needing to dissociate their interaction. Under these circum-
stances, the polymerase would move along the successive NP
monomers, using the exposed RNA sequence as a template and
extruding the mRNA transcript through the potential groove
proposed in Fig. 2. The structure of the RNP (36) and the data
presented here indicate that two separate polymerase–NP in-
teractions exist that show different contact surfaces (Figs. 2 E
and F and 5A). It is tempting to speculate that one of them is
repeatedly broken and reformed as the polymerase proceeds
along the RNP for transcription while the other is stably
maintained. Such a possibility would imply that the 5 terminus
of vRNA is located close to the more stable polymerase–NP
interaction. In this way, the polymerase could read the template
until the polyadenylation signal (14, 47), which is associated with
the last NP monomer, is reached. The conformational stress
determined by the proximity of the polyadenylation signal and
the 5 terminal sequence, still bound to the polymerase, would
induce the enzyme to stutter and synthesize the (poly)A tail.
The 3D structure described corresponds to an inactive form of
the polymerase bound to the vRNA promoter. Previous infor-
mation indicates that the purified RNPs used for structure
analysis contain mainly vRNA (35), and therefore the 3D model
of the polymerase presented here would correspond to the
complex poised for transcription but not yet activated by binding
to the cap primer. It is conceivable that the polymerase would
present a different structure in the absence of vRNA, as cap-
binding only occurs on recognition of the promoter 5 sequences
(48). Likewise, binding to the cRNA promoter may imply
structural alterations, because vRNA and cRNA panhandles are
recognized in different ways by the polymerase (22). On the
other hand, the replicating polymerase could present a number
of additional structural alterations as a consequence of its
interaction with soluble NP or with cellular factors like hCLE
(49) or Hsp90 (50).
In conclusion, the 3D model for the influenza polymerase
complex presented in this report provides structural information
about the viral enzyme, including the localization of specific
regions of their subunits.
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